In a significant stride for bio-innovation and the bioeconomy, Oobli, a leader in the global sweet protein market, has achieved a monumental milestone. The company proudly announces receipt of the "No questions" letter from the US Food & Drug Administration (FDA) for its groundbreaking Oubli Fruit Sweet Protein, brazzein, marking it as Generally Recognized as Safe (GRAS) for food and beverage applications.

Jason Ryder, Oobli Founder & CTO, and an Adjunct Professor at the University of California Berkeley, highlighted, "Oobli's mission transcends the present, ushering in a future where sweet proteins stand as a viable, healthful alternative to traditional and artificial sweeteners."

This FDA acknowledgment opens avenues for sweet proteins to diminish global sugar dependency significantly. Ali Wing, CEO of Oobli, emphasized the protein's potential to revolutionize food industries by substituting substantial sugar quantities in a range of products without impacting blood sugar or gut health.

Inspired by the Oobli Fruit's historical roots in West African culture, Oobli's innovation paves the way for widespread sugar reduction. "So sweet it makes children forget their mother's milk," the fruit's lore speaks volumes of its potential.

At FermenteQ, we recognize the profound impact of such innovations on the bioeconomy and are excited about the potential collaboration opportunities with Oobli. Our expertise in bioprocess engineering and fermenter design could significantly contribute to scaling Oobli's production, aligning with our shared vision for a healthier, sustainable future.

FermenteQ applauds Oobli's FDA achievement as a monumental leap towards reducing global sugar consumption and fostering a healthier populace. We are keen on exploring synergies that can accelerate the bioeconomy's growth, ensuring innovations like brazzein reach their full potential.

About FermenteQ: FermenteQ Innovations Inc. specializes in the development and manufacturing of cutting-edge bioreactors and fermenters. We are committed to advancing the bioeconomy through innovative solutions and collaborations that address the most pressing global health and sustainability challenges.

For collaboration inquiries or more information, please contact us at info@fermenteq.com.

© 2024 FermenteQ Innovations Inc. All rights reserved. Unauthorized reproduction, distribution, or transmission of this publication is strictly prohibited without prior written permission from FermenteQ Innovations Inc.

‍